Skip to main content
Erschienen in: Japanese Journal of Radiology 9/2016

23.07.2016 | Special Report

Ablation protocols and ancillary procedures in tumor ablation therapy: consensus from Japanese experts

verfasst von: Masaya Miyazaki, Toshihiro Iguchi, Haruyuki Takaki, Takashi Yamanaka, Yoshitaka Tamura, Hiroyuki Tokue, Yozo Sato, Osamu Ikeda, Tadashi Shimizu, Koichiro Yamakado

Erschienen in: Japanese Journal of Radiology | Ausgabe 9/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

A panel of Japanese experts on tumor ablation therapy gathered to reach a general consensus on topics surrounding ablation therapy.

Materials and methods

Questionnaires relating to ablation protocols for radiofrequency ablation (RFA) and cryoablation, as well as ancillary procedures required for safe and secure ablation therapy, were sent to seven institutions. Experts from these institutions discussed each topic based on the evidence and the questionnaire data, and a consensus was reached at an annual meeting of the Japan Image-guided Ablation Group in Maebashi, Japan, in October 2015.

Results

A consensus was reached on each of six topics, including “management of antiplatelet and anticoagulation drug therapy”; “pain control in the perioperative period”; “arterial embolization combined with ablation therapy”; “protection of non-target organs”; “RFA and cryoablation protocols”; and “ablative margins.”

Conclusions

The consensus achieved here will serve as the framework for tumor ablation therapies in Japan.
Literatur
1.
Zurück zum Zitat Ye X, Fan W, Chen JH, Feng WJ, Gu SZ, Han Y, et al. Chinese expert consensus workshop report: guidelines for thermal ablation of primary and metastatic lung tumors. Thorac Cancer. 2015;6(1):112–21.PubMedPubMedCentralCrossRef Ye X, Fan W, Chen JH, Feng WJ, Gu SZ, Han Y, et al. Chinese expert consensus workshop report: guidelines for thermal ablation of primary and metastatic lung tumors. Thorac Cancer. 2015;6(1):112–21.PubMedPubMedCentralCrossRef
2.
Zurück zum Zitat Yamanaka T, Yamakado K, Yamada T, Fujimori M, Takaki H, Nakatsuka A, et al. CT-guided percutaneous cryoablation in renal cell carcinoma: factors affecting local tumor control. J Vasc Interv Radiol: JVIR. 2015;26(8):1147–53.PubMedCrossRef Yamanaka T, Yamakado K, Yamada T, Fujimori M, Takaki H, Nakatsuka A, et al. CT-guided percutaneous cryoablation in renal cell carcinoma: factors affecting local tumor control. J Vasc Interv Radiol: JVIR. 2015;26(8):1147–53.PubMedCrossRef
3.
Zurück zum Zitat Nakatsuka A, Yamakado K, Uraki J, Takaki H, Yamanaka T, Fujimori M, et al. Safety and clinical outcomes of percutaneous radiofrequency ablation for intermediate and large bone tumors using a multiple-electrode switching system: a phase II clinical study. J Vasc Interv Radiol: JVIR. 2015. Nakatsuka A, Yamakado K, Uraki J, Takaki H, Yamanaka T, Fujimori M, et al. Safety and clinical outcomes of percutaneous radiofrequency ablation for intermediate and large bone tumors using a multiple-electrode switching system: a phase II clinical study. J Vasc Interv Radiol: JVIR. 2015.
4.
Zurück zum Zitat Kumasaka S, Miyazaki M, Tsushima Y. CT-guided percutaneous cryoablation of an aggressive osteoblastoma: a case report. J Vasc Interv Radiol: JVIR. 2015;26(11):1746–8.PubMedCrossRef Kumasaka S, Miyazaki M, Tsushima Y. CT-guided percutaneous cryoablation of an aggressive osteoblastoma: a case report. J Vasc Interv Radiol: JVIR. 2015;26(11):1746–8.PubMedCrossRef
5.
Zurück zum Zitat Yamakado K, Matsumine A, Nakamura T, Nakatsuka A, Takaki H, Matsubara T, et al. Radiofrequency ablation for the treatment of recurrent bone and soft-tissue sarcomas in non-surgical candidates. Int J Clin Oncol. 2014;19(5):955–62.PubMedCrossRef Yamakado K, Matsumine A, Nakamura T, Nakatsuka A, Takaki H, Matsubara T, et al. Radiofrequency ablation for the treatment of recurrent bone and soft-tissue sarcomas in non-surgical candidates. Int J Clin Oncol. 2014;19(5):955–62.PubMedCrossRef
6.
Zurück zum Zitat Takaki H, Yamakado K, Nakatsuka A, Yamada T, Uraki J, Kashima M, et al. Computed tomography fluoroscopy-guided radiofrequency ablation following intra-arterial iodized-oil injection for hepatocellular carcinomas invisible on ultrasonographic images. Int J Clin Oncol. 2013;18(1):46–53.PubMedCrossRef Takaki H, Yamakado K, Nakatsuka A, Yamada T, Uraki J, Kashima M, et al. Computed tomography fluoroscopy-guided radiofrequency ablation following intra-arterial iodized-oil injection for hepatocellular carcinomas invisible on ultrasonographic images. Int J Clin Oncol. 2013;18(1):46–53.PubMedCrossRef
7.
Zurück zum Zitat Iguchi T, Inoue D, Yabushita K, Sakaguchi K, Tatsukawa M, Sasaki H, et al. Effect of CT fluoroscopy-guided transpulmonary radiofrequency ablation of liver tumours on the lung. Br J Radiol. 1016;2012(85):e373–7. Iguchi T, Inoue D, Yabushita K, Sakaguchi K, Tatsukawa M, Sasaki H, et al. Effect of CT fluoroscopy-guided transpulmonary radiofrequency ablation of liver tumours on the lung. Br J Radiol. 1016;2012(85):e373–7.
8.
Zurück zum Zitat Atwell TD, Carter RE, Schmit GD, Carr CM, Boorjian SA, Curry TB, et al. Complications following 573 percutaneous renal radiofrequency and cryoablation procedures. J Vasc Interv Radiol: JVIR. 2012;23(1):48–54.PubMedCrossRef Atwell TD, Carter RE, Schmit GD, Carr CM, Boorjian SA, Curry TB, et al. Complications following 573 percutaneous renal radiofrequency and cryoablation procedures. J Vasc Interv Radiol: JVIR. 2012;23(1):48–54.PubMedCrossRef
9.
Zurück zum Zitat Miyazaki M, Aoki J, Miyazaki A, Nakajima T, Koyama Y, Shinozaki T, et al. Percutaneous radiofrequency ablation of osteoid osteoma using cool-tip electrodes without the cooling system. Jpn J Radiol. 2011;29(2):138–43.PubMedCrossRef Miyazaki M, Aoki J, Miyazaki A, Nakajima T, Koyama Y, Shinozaki T, et al. Percutaneous radiofrequency ablation of osteoid osteoma using cool-tip electrodes without the cooling system. Jpn J Radiol. 2011;29(2):138–43.PubMedCrossRef
10.
Zurück zum Zitat Yasui K, Kanazawa S, Sano Y, Fujiwara T, Kagawa S, Mimura H, et al. Thoracic tumors treated with CT-guided radiofrequency ablation: initial experience. Radiology. 2004;231(3):850–7.PubMedCrossRef Yasui K, Kanazawa S, Sano Y, Fujiwara T, Kagawa S, Mimura H, et al. Thoracic tumors treated with CT-guided radiofrequency ablation: initial experience. Radiology. 2004;231(3):850–7.PubMedCrossRef
11.
Zurück zum Zitat Yamakado K, Nakatsuka A, Akeboshi M, Takeda K. Percutaneous radiofrequency ablation of liver neoplasms adjacent to the gastrointestinal tract after balloon catheter interposition. J Vasc Interv Radiol: JVIR. 2003;14(9 Pt 1):1183–6.PubMedCrossRef Yamakado K, Nakatsuka A, Akeboshi M, Takeda K. Percutaneous radiofrequency ablation of liver neoplasms adjacent to the gastrointestinal tract after balloon catheter interposition. J Vasc Interv Radiol: JVIR. 2003;14(9 Pt 1):1183–6.PubMedCrossRef
12.
Zurück zum Zitat Gillams A, Goldberg N, Ahmed M, Bale R, Breen D, Callstrom M, et al. Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, the Interventional Oncology Sans Frontieres meeting 2013. Eur Radiol. 2015;25(12):3438–54.PubMedPubMedCentralCrossRef Gillams A, Goldberg N, Ahmed M, Bale R, Breen D, Callstrom M, et al. Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, the Interventional Oncology Sans Frontieres meeting 2013. Eur Radiol. 2015;25(12):3438–54.PubMedPubMedCentralCrossRef
13.
Zurück zum Zitat Ahmed M, Solbiati L, Brace CL, Breen DJ, Callstrom MR, Charboneau JW, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria—a 10-year update. J Vasc Interv Radiol: JVIR. 2014;25(11):1691–705, e4. Ahmed M, Solbiati L, Brace CL, Breen DJ, Callstrom MR, Charboneau JW, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria—a 10-year update. J Vasc Interv Radiol: JVIR. 2014;25(11):1691–705, e4.
14.
Zurück zum Zitat Takaki H, Yamakado K, Nakatsuka A, Yamada T, Shiraki K, Takei Y, et al. Frequency of and risk factors for complications after liver radiofrequency ablation under CT fluoroscopic guidance in 1500 sessions: single-center experience. AJR Am J Roentgenol. 2013;200(3):658–64.PubMedCrossRef Takaki H, Yamakado K, Nakatsuka A, Yamada T, Shiraki K, Takei Y, et al. Frequency of and risk factors for complications after liver radiofrequency ablation under CT fluoroscopic guidance in 1500 sessions: single-center experience. AJR Am J Roentgenol. 2013;200(3):658–64.PubMedCrossRef
15.
Zurück zum Zitat Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology. 2003;226(2):441–51.PubMedCrossRef Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology. 2003;226(2):441–51.PubMedCrossRef
16.
Zurück zum Zitat Zargar H, Atwell TD, Cadeddu JA, de la Rosette JJ, Janetschek G, Kaouk JH, et al. Cryoablation for small renal masses: selection criteria, complications, and functional and oncologic results. Eur Urol. 2016;69(1):116–28.PubMedCrossRef Zargar H, Atwell TD, Cadeddu JA, de la Rosette JJ, Janetschek G, Kaouk JH, et al. Cryoablation for small renal masses: selection criteria, complications, and functional and oncologic results. Eur Urol. 2016;69(1):116–28.PubMedCrossRef
17.
Zurück zum Zitat Guidelines for the management of anticoagulant and antiplatelet therapy in patients with cardiovascular diseases. Japanese Circulation Society. 2009. Guidelines for the management of anticoagulant and antiplatelet therapy in patients with cardiovascular diseases. Japanese Circulation Society. 2009.
18.
Zurück zum Zitat Grines CL, Bonow RO, Casey DE Jr, Gardner TJ, Lockhart PB, Moliterno DJ, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. J Am Dent Assoc. 2007;138(5):652–5.PubMedCrossRef Grines CL, Bonow RO, Casey DE Jr, Gardner TJ, Lockhart PB, Moliterno DJ, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. J Am Dent Assoc. 2007;138(5):652–5.PubMedCrossRef
19.
Zurück zum Zitat Maulaz AB, Bezerra DC, Michel P, Bogousslavsky J. Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke. Arch Neurol. 2005;62(8):1217–20.PubMedCrossRef Maulaz AB, Bezerra DC, Michel P, Bogousslavsky J. Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke. Arch Neurol. 2005;62(8):1217–20.PubMedCrossRef
20.
Zurück zum Zitat Eikelboom JW, Hirsh J, Spencer FA, Baglin TP, Weitz JI. Antiplatelet drugs: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e89S–119S.PubMedPubMedCentralCrossRef Eikelboom JW, Hirsh J, Spencer FA, Baglin TP, Weitz JI. Antiplatelet drugs: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e89S–119S.PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. New Engl J Med. 2009;361(12):1139–51.PubMedCrossRef Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. New Engl J Med. 2009;361(12):1139–51.PubMedCrossRef
22.
Zurück zum Zitat Douketis JD, Spyropoulos AC, Kaatz S, Becker RC, Caprini JA, Dunn AS, et al. Perioperative bridging anticoagulation in patients with atrial fibrillation. New Engl J Med. 2015;373(9):823–33.PubMedPubMedCentralCrossRef Douketis JD, Spyropoulos AC, Kaatz S, Becker RC, Caprini JA, Dunn AS, et al. Perioperative bridging anticoagulation in patients with atrial fibrillation. New Engl J Med. 2015;373(9):823–33.PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat de Baere T. Lung tumor radiofrequency ablation: where do we stand? Cardiovasc Interv Radiol. 2011;34(2):241–51.CrossRef de Baere T. Lung tumor radiofrequency ablation: where do we stand? Cardiovasc Interv Radiol. 2011;34(2):241–51.CrossRef
24.
Zurück zum Zitat Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg. 2005;242(2):158–71.PubMedPubMedCentralCrossRef Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg. 2005;242(2):158–71.PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Sofocleous CT, Sideras P, Petre EN. “How we do it”—a practical approach to hepatic metastases ablation techniques. Tech Vasc Interv Radiol. 2013;16(4):219–29.PubMedCrossRef Sofocleous CT, Sideras P, Petre EN. “How we do it”—a practical approach to hepatic metastases ablation techniques. Tech Vasc Interv Radiol. 2013;16(4):219–29.PubMedCrossRef
26.
Zurück zum Zitat Yokoyama K, Ikeda O, Kawanaka K, Nakasone Y, Inoue S, Tamura Y, et al. Pain control in patients with hepatocellular carcinoma treated by percutaneous radiofrequency ablation: comparison of the efficacy of one-shot and continuous intravenous fentanyl delivery. Acta Radiol. 2014;55(10):1219–25.PubMedCrossRef Yokoyama K, Ikeda O, Kawanaka K, Nakasone Y, Inoue S, Tamura Y, et al. Pain control in patients with hepatocellular carcinoma treated by percutaneous radiofrequency ablation: comparison of the efficacy of one-shot and continuous intravenous fentanyl delivery. Acta Radiol. 2014;55(10):1219–25.PubMedCrossRef
27.
Zurück zum Zitat Kang TW, Rhim H, Lee MW, Kim YS, Choi D, Lee WJ, et al. Radiofrequency ablation for hepatocellular carcinoma abutting the diaphragm: comparison of effects of thermal protection and therapeutic efficacy. AJR Am J Roentgenol. 2011;196(4):907–13.PubMedCrossRef Kang TW, Rhim H, Lee MW, Kim YS, Choi D, Lee WJ, et al. Radiofrequency ablation for hepatocellular carcinoma abutting the diaphragm: comparison of effects of thermal protection and therapeutic efficacy. AJR Am J Roentgenol. 2011;196(4):907–13.PubMedCrossRef
28.
Zurück zum Zitat Okuma T, Matsuoka T, Yamamoto A, Oyama Y, Toyoshima M, Nakamura K, et al. Frequency and risk factors of various complications after computed tomography-guided radiofrequency ablation of lung tumors. Cardiovasc Interv Radiol. 2008;31(1):122–30.CrossRef Okuma T, Matsuoka T, Yamamoto A, Oyama Y, Toyoshima M, Nakamura K, et al. Frequency and risk factors of various complications after computed tomography-guided radiofrequency ablation of lung tumors. Cardiovasc Interv Radiol. 2008;31(1):122–30.CrossRef
29.
Zurück zum Zitat Gazzera C, Fonio P, Faletti R, Dotto MC, Gobbi F, Donadio P, et al. Role of paravertebral block anaesthesia during percutaneous transhepatic thermoablation. Radiol Med (Torino). 2014;119(8):549–57.CrossRef Gazzera C, Fonio P, Faletti R, Dotto MC, Gobbi F, Donadio P, et al. Role of paravertebral block anaesthesia during percutaneous transhepatic thermoablation. Radiol Med (Torino). 2014;119(8):549–57.CrossRef
30.
Zurück zum Zitat Hiraki T, Gobara H, Shibamoto K, Mimura H, Soda Y, Uka M, et al. Technique for creation of artificial pneumothorax for pain relief during radiofrequency ablation of peripheral lung tumors: report of seven cases. J Vasc Interv Radiol: JVIR. 2011;22(4):503–6.PubMedCrossRef Hiraki T, Gobara H, Shibamoto K, Mimura H, Soda Y, Uka M, et al. Technique for creation of artificial pneumothorax for pain relief during radiofrequency ablation of peripheral lung tumors: report of seven cases. J Vasc Interv Radiol: JVIR. 2011;22(4):503–6.PubMedCrossRef
31.
Zurück zum Zitat Allaf ME, Varkarakis IM, Bhayani SB, Inagaki T, Kavoussi LR, Solomon SB. Pain control requirements for percutaneous ablation of renal tumors: cryoablation versus radiofrequency ablation—initial observations. Radiology. 2005;237(1):366–70.PubMedCrossRef Allaf ME, Varkarakis IM, Bhayani SB, Inagaki T, Kavoussi LR, Solomon SB. Pain control requirements for percutaneous ablation of renal tumors: cryoablation versus radiofrequency ablation—initial observations. Radiology. 2005;237(1):366–70.PubMedCrossRef
32.
Zurück zum Zitat Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19(3):329–38.PubMedCrossRef Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19(3):329–38.PubMedCrossRef
33.
Zurück zum Zitat Miyayama S, Yamakado K, Anai H, Abo D, Minami T, Takaki H, et al. Guidelines on the use of gelatin sponge particles in embolotherapy. Jpn J Radiol. 2014;32(4):242–50.PubMedCrossRef Miyayama S, Yamakado K, Anai H, Abo D, Minami T, Takaki H, et al. Guidelines on the use of gelatin sponge particles in embolotherapy. Jpn J Radiol. 2014;32(4):242–50.PubMedCrossRef
34.
Zurück zum Zitat Yamanaka T, Yamakado K, Takaki H, Nakatsuka A, Shiraki K, Hasegawa H, et al. Ablative zone size created by radiofrequency ablation with and without chemoembolization in small hepatocellular carcinomas. Jpn J Radiol. 2012;30(7):553–9.PubMedCrossRef Yamanaka T, Yamakado K, Takaki H, Nakatsuka A, Shiraki K, Hasegawa H, et al. Ablative zone size created by radiofrequency ablation with and without chemoembolization in small hepatocellular carcinomas. Jpn J Radiol. 2012;30(7):553–9.PubMedCrossRef
35.
Zurück zum Zitat Sugimori K, Nozawa A, Morimoto M, Shirato K, Kokawa A, Saito T, et al. Extension of radiofrequency ablation of the liver by transcatheter arterial embolization with iodized oil and gelatin sponge: results in a pig model. J Vasc Interv Radiol: JVIR. 2005;16(6):849–56.PubMedCrossRef Sugimori K, Nozawa A, Morimoto M, Shirato K, Kokawa A, Saito T, et al. Extension of radiofrequency ablation of the liver by transcatheter arterial embolization with iodized oil and gelatin sponge: results in a pig model. J Vasc Interv Radiol: JVIR. 2005;16(6):849–56.PubMedCrossRef
36.
Zurück zum Zitat Dong W, Zhang T, Wang ZG, Liu H. Clinical outcome of small hepatocellular carcinoma after different treatments: a meta-analysis. World J Gastroenterol. 2014;20(29):10174–82.PubMedPubMedCentralCrossRef Dong W, Zhang T, Wang ZG, Liu H. Clinical outcome of small hepatocellular carcinoma after different treatments: a meta-analysis. World J Gastroenterol. 2014;20(29):10174–82.PubMedPubMedCentralCrossRef
37.
Zurück zum Zitat Ni JY, Liu SS, Xu LF, Sun HL, Chen YT. Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol. 2013;19(24):3872–82.PubMedPubMedCentralCrossRef Ni JY, Liu SS, Xu LF, Sun HL, Chen YT. Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol. 2013;19(24):3872–82.PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Rhim H, Lee MH, Kim YS, Choi D, Lee WJ, Lim HK. Planning sonography to assess the feasibility of percutaneous radiofrequency ablation of hepatocellular carcinomas. AJR Am J Roentgenol. 2008;190(5):1324–30.PubMedCrossRef Rhim H, Lee MH, Kim YS, Choi D, Lee WJ, Lim HK. Planning sonography to assess the feasibility of percutaneous radiofrequency ablation of hepatocellular carcinomas. AJR Am J Roentgenol. 2008;190(5):1324–30.PubMedCrossRef
39.
Zurück zum Zitat Goto E, Tateishi R, Shiina S, Masuzaki R, Enooku K, Sato T, et al. Hemorrhagic complications of percutaneous radiofrequency ablation for liver tumors. J Clin Gastroenterol. 2010;44(5):374–80.PubMed Goto E, Tateishi R, Shiina S, Masuzaki R, Enooku K, Sato T, et al. Hemorrhagic complications of percutaneous radiofrequency ablation for liver tumors. J Clin Gastroenterol. 2010;44(5):374–80.PubMed
40.
Zurück zum Zitat Chen JX, Guzzo TJ, Malkowicz SB, Soulen MC, Wein AJ, Clark TW, et al. Complication and readmission rates following same-day discharge after percutaneous renal tumor ablation. J Vasc Interv Radiol: JVIR. 2016;27(1):80–6.PubMedCrossRef Chen JX, Guzzo TJ, Malkowicz SB, Soulen MC, Wein AJ, Clark TW, et al. Complication and readmission rates following same-day discharge after percutaneous renal tumor ablation. J Vasc Interv Radiol: JVIR. 2016;27(1):80–6.PubMedCrossRef
41.
Zurück zum Zitat Miller JM, Julien P, Wachsman A, Van Allan RJ, Friedman ML. The role of embolization in reducing the complications of cryoablation in renal cell carcinoma. Clin Radiol. 2014;69(10):1045–9.PubMedCrossRef Miller JM, Julien P, Wachsman A, Van Allan RJ, Friedman ML. The role of embolization in reducing the complications of cryoablation in renal cell carcinoma. Clin Radiol. 2014;69(10):1045–9.PubMedCrossRef
42.
Zurück zum Zitat Gervais DA, Arellano RS, McGovern FJ, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 2. Lessons learned with ablation of 100 tumors. AJR Am J Roentgenol. 2005;185(1):72–80.PubMedCrossRef Gervais DA, Arellano RS, McGovern FJ, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 2. Lessons learned with ablation of 100 tumors. AJR Am J Roentgenol. 2005;185(1):72–80.PubMedCrossRef
43.
Zurück zum Zitat Campbell C, Lubner MG, Hinshaw JL, Munoz del Rio A, Brace CL. Contrast media-doped hydrodissection during thermal ablation: optimizing contrast media concentration for improved visibility on CT images. AJR. Am J Roentgenol. 2012;199(3):677–82.CrossRef Campbell C, Lubner MG, Hinshaw JL, Munoz del Rio A, Brace CL. Contrast media-doped hydrodissection during thermal ablation: optimizing contrast media concentration for improved visibility on CT images. AJR. Am J Roentgenol. 2012;199(3):677–82.CrossRef
44.
Zurück zum Zitat Hasegawa T, Takaki H, Miyagi H, Nakatsuka A, Uraki J, Yamanaka T, et al. Hyaluronic acid gel injection to prevent thermal injury of adjacent gastrointestinal tract during percutaneous liver radiofrequency ablation. Cardiovasc Interv Radiol. 2013;36(4):1144–6.CrossRef Hasegawa T, Takaki H, Miyagi H, Nakatsuka A, Uraki J, Yamanaka T, et al. Hyaluronic acid gel injection to prevent thermal injury of adjacent gastrointestinal tract during percutaneous liver radiofrequency ablation. Cardiovasc Interv Radiol. 2013;36(4):1144–6.CrossRef
46.
Zurück zum Zitat Rosenthal DI, Hornicek FJ, Torriani M, Gebhardt MC, Mankin HJ. Osteoid osteoma: percutaneous treatment with radiofrequency energy. Radiology. 2003;229(1):171–5.PubMedCrossRef Rosenthal DI, Hornicek FJ, Torriani M, Gebhardt MC, Mankin HJ. Osteoid osteoma: percutaneous treatment with radiofrequency energy. Radiology. 2003;229(1):171–5.PubMedCrossRef
48.
Zurück zum Zitat Wang C, Wang H, Yang W, Hu K, Xie H, Hu KQ, et al. Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma. Hepatology. 2015;61(5):1579–90.PubMedCrossRef Wang C, Wang H, Yang W, Hu K, Xie H, Hu KQ, et al. Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma. Hepatology. 2015;61(5):1579–90.PubMedCrossRef
49.
Zurück zum Zitat Ni Y, Mulier S, Miao Y, Michel L, Marchal G. A review of the general aspects of radiofrequency ablation. Abdom Imaging. 2005;30(4):381–400.PubMedCrossRef Ni Y, Mulier S, Miao Y, Michel L, Marchal G. A review of the general aspects of radiofrequency ablation. Abdom Imaging. 2005;30(4):381–400.PubMedCrossRef
50.
Zurück zum Zitat Georgiades C, Rodriguez R, Azene E, Weiss C, Chaux A, Gonzalez-Roibon N, et al. Determination of the nonlethal margin inside the visible “ice-ball” during percutaneous cryoablation of renal tissue. Cardiovasc Interv Radiol. 2013;36(3):783–90.CrossRef Georgiades C, Rodriguez R, Azene E, Weiss C, Chaux A, Gonzalez-Roibon N, et al. Determination of the nonlethal margin inside the visible “ice-ball” during percutaneous cryoablation of renal tissue. Cardiovasc Interv Radiol. 2013;36(3):783–90.CrossRef
Metadaten
Titel
Ablation protocols and ancillary procedures in tumor ablation therapy: consensus from Japanese experts
verfasst von
Masaya Miyazaki
Toshihiro Iguchi
Haruyuki Takaki
Takashi Yamanaka
Yoshitaka Tamura
Hiroyuki Tokue
Yozo Sato
Osamu Ikeda
Tadashi Shimizu
Koichiro Yamakado
Publikationsdatum
23.07.2016
Verlag
Springer Japan
Erschienen in
Japanese Journal of Radiology / Ausgabe 9/2016
Print ISSN: 1867-1071
Elektronische ISSN: 1867-108X
DOI
https://doi.org/10.1007/s11604-016-0569-8

Weitere Artikel der Ausgabe 9/2016

Japanese Journal of Radiology 9/2016 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.